Tenax Announces Issuance of U.S. Patent Covering Use of IV Levosimendan in Pulmonary Hypertension with Heart Failure with Preserved Ejection Fraction (PH-HFpEF)
Stock Information for Tenax Therapeutics Inc.
Loading
Please wait while we load your information from QuoteMedia.